Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)
Hong Kong
· Delayed Price · Currency is HKD 5.64
+0.02 (0.36%)
Mar 3, 2025, 4:08 PM HKT
HKG:0719 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 28, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 8,927 | 11,897 | 17,740 | 6,846 | 5,447 | 4,336 | Upgrade
|
| Market Cap Growth | -10.11% | -32.94% | 159.14% | 25.67% | 25.64% | 27.25% | Upgrade
|
| Enterprise Value | 9,728 | 12,706 | 17,708 | 8,175 | 6,459 | 5,408 | Upgrade
|
| Last Close Price | 5.64 | 5.46 | 7.41 | 4.12 | 3.01 | 3.14 | Upgrade
|
| PE Ratio | 7.83 | 21.75 | 38.17 | 16.00 | 14.12 | 12.92 | Upgrade
|
| PS Ratio | 0.42 | 1.33 | 2.09 | 0.85 | 0.76 | 0.69 | Upgrade
|
| PB Ratio | 0.71 | 2.26 | 3.61 | 1.53 | 1.35 | 1.25 | Upgrade
|
| P/TBV Ratio | 2.12 | 2.66 | 4.30 | 1.86 | 1.65 | 1.52 | Upgrade
|
| P/FCF Ratio | 20.78 | - | 30.56 | 563.90 | 32.76 | - | Upgrade
|
| P/OCF Ratio | 20.93 | 40.71 | 20.70 | 21.52 | 10.92 | 11.13 | Upgrade
|
| EV/Sales Ratio | 1.05 | 1.42 | 2.09 | 1.02 | 0.91 | 0.86 | Upgrade
|
| EV/EBITDA Ratio | 8.70 | 11.27 | 16.45 | 7.93 | 6.45 | 6.59 | Upgrade
|
| EV/EBIT Ratio | 18.42 | 22.52 | 33.62 | 16.50 | 11.85 | 12.39 | Upgrade
|
| EV/FCF Ratio | 51.96 | - | 30.51 | 673.39 | 38.85 | - | Upgrade
|
| Debt / Equity Ratio | 0.33 | 0.28 | 0.32 | 0.45 | 0.49 | 0.49 | Upgrade
|
| Debt / EBITDA Ratio | 1.64 | 1.32 | 1.45 | 1.95 | 1.95 | 2.08 | Upgrade
|
| Debt / FCF Ratio | 9.80 | - | 2.70 | 166.46 | 11.75 | - | Upgrade
|
| Asset Turnover | 1.00 | 0.98 | 0.96 | 0.91 | 0.89 | 0.91 | Upgrade
|
| Inventory Turnover | 5.66 | 4.58 | 4.92 | 4.48 | 3.76 | 3.64 | Upgrade
|
| Quick Ratio | 0.84 | 0.76 | 0.68 | 0.65 | 0.59 | 0.47 | Upgrade
|
| Current Ratio | 1.34 | 1.33 | 1.09 | 1.10 | 1.13 | 0.98 | Upgrade
|
| Return on Equity (ROE) | 9.42% | 11.09% | 10.65% | 10.28% | 10.68% | 10.91% | Upgrade
|
| Return on Assets (ROA) | 3.56% | 3.87% | 3.73% | 3.50% | 4.24% | 3.94% | Upgrade
|
| Return on Capital (ROIC) | 4.65% | 5.39% | 5.28% | 4.88% | 5.93% | 5.49% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.79% | 8.83% | 9.12% | 8.36% | 9.74% | 9.88% | Upgrade
|
| Earnings Yield | 5.57% | 4.60% | 2.62% | 6.25% | 7.08% | 7.74% | Upgrade
|
| FCF Yield | 2.10% | -0.55% | 3.27% | 0.18% | 3.05% | -0.47% | Upgrade
|
| Dividend Yield | 0.95% | 5.05% | 3.05% | 4.47% | 5.92% | 4.28% | Upgrade
|
| Payout Ratio | 49.97% | 35.43% | 39.66% | 42.59% | 39.05% | 38.80% | Upgrade
|
| Buyback Yield / Dilution | -0.91% | -3.20% | -6.92% | 0.02% | -0.86% | 0.14% | Upgrade
|
| Total Shareholder Return | 0.04% | 1.85% | -3.87% | 4.48% | 5.06% | 4.41% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.